Graphical Abstract (image) Duke-NUS Medical School Share Print E-Mail Caption Workflow of how: 1) eligible patients and the appropriate HBV-specific T cells are selected and 2) T cells are engineered, for T cell therapy of HBV-HCC. Credit Gastroenterology Usage Restrictions This image may only be used with an appropriate caption (as prescribed here) and credit. Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.